Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Severe hypophosphataemia following oral bisphosphonate treatment in a patient with osteoporosis

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Extensive extraintestinal manifestations of ulcerative colitis in a patient initially suspected to have disseminated malignancy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Internal bowel herniation through a peritoneal defect between the right fallopian tube and right ovarian vessels

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Spontaneous intracranial hypotension presenting with progressive cognitive decline

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Severe influenza in a paediatric patient with GATA2 deficiency and Emberger syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Severe acute hepatitis E infection presenting with acute abdomen and meningoencephalitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Denosumab vs. zoledronic acid treatment in post-menopausal breast cancer: a 2-year prospective observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Republished: Severe hypophosphataemia following oral bisphosphonate treatment in a patient with osteoporosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Does vascular endothelial dysfunction play a role in physical frailty and sarcopenia? A systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  4. RANKL regulates male reproductive function

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Louise Wulff Bagger
  • Per Kim Dyhr Hansen
  • Peter Schwarz
  • Barbara Rubek Nielsen
View graph of relations

A 76-year-old woman was treated with oral bisphosphonate, alendronate, for osteoporosis in an outpatient clinic. Routine blood tests 4 months after alendronate prescription surprisingly revealed severe hypophosphataemia. The patient was hospitalised and treated with intravenous and oral phosphate supplements. Alendronate was later reintroduced as treatment for osteoporosis and the patient once again presented with severe hypophosphataemia in subsequent routine blood tests. The patient had only presented with lower extremity pain, muscle weakness and difficulty walking. Blood tests in the emergency department both times reconfirmed severe hypophosphataemia. Plasma (p-)ionised calcium levels were normal or slightly elevated and p-parathyroid hormone levels were normal or slightly suppressed. The p-25-hydroxyvitamin-D and p-creatine were in the normal range. Critical illness, malabsorption, nutritional issues and genetics were reviewed as potential causes but considered unlikely. Phosphate levels were quickly restored each time on replacement therapy and the case was interpreted as bisphosphonate-induced severe hypophosphataemia.

Original languageEnglish
JournalBMJ Case Reports
Volume13
Issue number10
ISSN1757-790X
DOIs
Publication statusPublished - 8 Oct 2020

    Research areas

  • calcium and bone, drugs: endocrine system, geriatric medicine, unwanted effects / adverse reactions

ID: 61114747